Covidien announced at CIRSE 2012 (15–19 September, Lisbon, Portugal) the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs). The devices are now available in the United States, the European Union and other select international markets.
“Management of the lower extremity CTO remains challenging for endovascular physicians,” said David B Jessup, PeaceHealth St Joseph Medical Center in Bellingham, Washington, USA. “Effective devices for CTO crossing and re-entry can expand the number of patients who have access to endovascular treatment of peripheral arterial disease, which may help patients avoid more invasive treatments and allow physicians to offer amputation-saving procedures.”
Competitive crossing devices rely on more aggressive cutting, grinding or pounding motions and can be more difficult to control. Moreover, the distinctive shape of the re-entry balloon enables it to self-orient within the vessel. According to a company release, no other product on the market utilises this balloon technology for a re-entry system.